Research / Products
Hypothetical product specifications
Research-stage product specifications — manufacturing notes, QA protocols, regulatory pathway analyses. Not commerce. Email-only waitlists if you want to be notified when (or if) a spec graduates to legal-today commerce.
Hard rule
Two of these specs describe controlled substances. They are NOT for sale.
Psilocybin is Schedule I under federal law as of this writing. The microdose capsule and therapeutic lozenge specs exist as engineering documentation — what we'd build if/when the regulatory pathway opens. They are not pre-orders. We will never accept payment for a controlled substance in violation of federal law. The waitlist signup is purely for "email me if/when this becomes legal commerce."
Standardized Microdose Capsule — 2 mg
Research-stage spec for a federally-compliant 2 mg psilocybin capsule, manufactured under cGMP.
- Active
- Psilocybin (4-PO-DMT)
- Dose
- 2 mg / serving
- Form factor
- Hard-shell vegetarian capsule, size #4
Read full spec →
Therapeutic-Dose Sublingual Lozenge — 25 mg
Research-stage spec for a sublingual 25 mg psilocybin lozenge designed for guided-therapy contexts.
- Active
- Psilocybin (4-PO-DMT)
- Dose
- 25 mg / serving
- Form factor
- Sublingual lozenge, ~750 mg total mass, citrus-mint flavor base
Read full spec →
Ultrasonic-Extracted Lion's Mane + Reishi Functional Tincture
Research-stage spec for a high-concentration tincture using bench-scale ultrasonic extraction.
- Active
- Hericenones (lion's mane) + triterpenes (reishi)
- Dose
- 500 mg / serving
- Form factor
- 1 fl oz dropper bottle, 30 servings
Read full spec →